Clinical Trials

Our Clinical Trials system is temporarily offline. Sorry for any inconvenience this may cause.

NCT ID	Study Title	Action
NCT05431270	Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)	View
NCT04306939	Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study	View
NCT04612530	PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer	View
NCT07255001	Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life	View
NCT07528430	Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer	View
NCT04805307	Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901	View
NCT00416507	Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery	View

Would you like to subscribe to receive updates?

National Pancreatic Cancer Foundation provides access to clinical research studies. This information is provided by clinicaltrials.gov and is maintained by the National Library of Medicine (NLM). Neither NPCF nor the US government review or approve the safety and science of the studies on this website. Read the disclaimer for details.

Learn

Resources

Patients

Caregivers

Clinical Trials

Would you like to subscribe to receive updates?

About

Events

Fundraising

Contact Us

Learn

Resources

Patients

Caregivers

Learn

Resources

Patients

Caregivers

Clinical Trials

Would you like to subscribe to receive updates?

Learn

Resources

Patients

Caregivers

Make-A-Will Month